×
Azenta EBITDA 2010-2024 | AZTA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Azenta ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Historical Chart (TTM)
Quarterly
Annual
Quarterly - YOY Change
Annual % Change
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$37.1B
Hims & Hers Health (HIMS)
$14.5B
Tempus AI (TEM)
$12.1B
Inspire Medical Systems (INSP)
$5.3B
IRhythm Technologies (IRTC)
$3.5B
Privia Health (PRVA)
$3B
Enovis (ENOV)
$2.5B
Clover Health Investments (CLOV)
$2.2B
Omnicell (OMCL)
$1.8B
Schrodinger (SDGR)
$1.7B
Phreesia (PHR)
$1.7B
10x Genomics (TXG)
$1.4B
Butterfly Network (BFLY)
$944M
Talkspace (TALK)
$556M
Fulgent Genetics (FLGT)
$509M
Standard BioTools (LAB)
$503M
TruBridge (TBRG)
$417M
Nyxoah SA (NYXH)
$354M
Pulmonx (LUNG)
$347M
Health Catalyst (HCAT)
$328M
SOPHiA GENETICS SA (SOPH)
$277M
American Well (AMWL)
$188M
EUDA Health Holdings (EUDA)
$101M
MDxHealth SA (MDXH)
$88M
P3 Health Partners (PIII)
$78M
111 (YI)
$70M
CareCloud (CCLD)
$61M
HeartBeam (BEAT)
$56M
Outset Medical (OM)
$52M
Zepp Health (ZEPP)
$45M